We are live on ! Find out more
AVBP icon

ArriVent BioPharma
AVBP

99 hedge funds and large institutions have $732M invested in ArriVent BioPharma in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

189% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 9

36% more capital invested

Capital invested by funds: $539M → $732M (+$193M)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

19% more funds holding

Funds holding: 83 → 99 (+16)

12.82% more ownership

Funds ownership: 85.46% → 98.29% (+13%)

17% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 30

Holders
99
Holders Change
+16
Holders Change %
+19.28%
% of All Funds
1.3%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
26
Increased
25
Reduced
30
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IAM
Infinitum Asset Management
Florida
+$28.1M
2
SCM
Suvretta Capital Management
New York
+$22.3M
3
SL
Siren LLC
Connecticut
+$14.5M
4
F1I
Fund 1 Investments
Puerto Rico
+$11M
5
CLG
Cooperman Leon G
+$8.75M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$6.26M
2
UBS Group
UBS Group
Switzerland
-$2.4M
3
OCA
Octagon Capital Advisors
New York
-$2.35M
4
Two Sigma Investments
Two Sigma Investments
New York
-$765K
5
Marshall Wace
Marshall Wace
United Kingdom
-$663K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
51
Invesco
Georgia
$328K -$1.68K -81 -0.5%
Legal & General Group
52
Legal & General Group
United Kingdom
$322K +$24.9K +1,197 +9%
JP Morgan Chase
53
JP Morgan Chase
New York
$314K -$39.9K -1,920 -12%
AQR Capital Management
54
AQR Capital Management
Connecticut
$312K +$298K +14,336 New
Balyasny Asset Management
55
Balyasny Asset Management
Illinois
$311K +$297K +14,292 New
IIM
56
INTECH Investment Management
Florida
$293K -$95.7K -4,608 -26%
Mirae Asset Global ETFs Holdings
57
Mirae Asset Global ETFs Holdings
Hong Kong
$293K -$86K -4,143 -24%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$283K -$13K -627 -5%
AC
59
AXQ Capital
New Jersey
$277K +$264K +12,735 New
VF
60
Virtu Financial
New York
$273K +$260K +12,530 New
Wells Fargo
61
Wells Fargo
California
$259K -$60.5K -2,916 -20%
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
$250K -$21.1K -1,018 -8%
BHCM
63
Brevan Howard Capital Management
Jersey
$209K +$199K +9,592 New
Walleye Capital
64
Walleye Capital
New York
$206K +$196K +9,454 New
ACM
65
Aster Capital Management
United Arab Emirates
$190K +$175K +8,449 +3,007%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$169K – – –
CUAMC
67
China Universal Asset Management Company
China
$150K +$2.33K +112 +2%
TRCT
68
Tower Research Capital (TRC)
New York
$145K +$118K +5,676 +572%
PFSRSONJ
69
Police & Firemen's Retirement System of New Jersey
New Jersey
$136K – – –
WC
70
Wexford Capital
Florida
$120K +$115K +5,519 New
VIA
71
Virtus Investment Advisers
Connecticut
$86.6K -$49.2K -2,369 -37%
KK
72
KLP Kapitalforvaltning
Norway
$67.5K – – –
BNP Paribas Financial Markets
73
BNP Paribas Financial Markets
France
$56K +$12.6K +609 +31%
AIP
74
Ameritas Investment Partners
Nebraska
$51.2K -$10.4K -502 -18%
Mirae Asset Global Investments
75
Mirae Asset Global Investments
South Korea
$28.8K +$4.03K +194 +17%
1 2
3
4 5

AVBP Hedge Fund Activity: Q2 2025 in Review

99 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ArriVent BioPharma (AVBP) for Q2 2025, worth a combined $732M — up 36% from $539M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new AVBP positions and 9 closed out — a net gain of 17 holders — while 25 added to existing stakes and 30 trimmed.

The largest buyer was Infinitum Asset Management, adding an estimated $28.1M. The largest seller was BlackRock, cutting an estimated $6.26M.

  • 99 institutional investors held ArriVent BioPharma (AVBP) as of Q2 2025, up from 83 in Q1 2025.
  • Funds reported $732M of ArriVent BioPharma stock for Q2 2025, up 36% quarter-over-quarter.
  • 26 funds opened new ArriVent BioPharma positions in Q2 2025 and 9 closed out, a net change of +17 holders.
  • The largest ArriVent BioPharma buyer in Q2 2025 was Infinitum Asset Management, an estimated $28.1M added.
  • The largest ArriVent BioPharma seller in Q2 2025 was BlackRock, an estimated $6.26M sold.

Based on aggregated 13F filings for Q2 2025.